Endo International Overview
- Year Founded
-
1920
- Status
-
Acquired/Merged
- Employees
-
3,000
- Latest Deal Type
-
Debt Refin.
- (Cancelled)
- Financing Rounds
-
21
- Investments
-
25
Endo International General Information
Description
Manufacturer of specialty pharmaceuticals designed to meet unique medical needs. The company offers a broad range of life-enhancing therapies, including intelligent product selection, branded pharmaceuticals, sterile injectables, generic pharmaceuticals, international pharmaceuticals, and a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. enabling healthcare providers and patients worldwide to improve quality of life through effective treatments.
Contact Information
Website
www.endo.comCorporate Office
- 9 Great Valley Parkway
- PA 19355
- United States
Corporate Office
- 9 Great Valley Parkway
- PA 19355
- United States
Endo International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Endo International Comparisons
Industry
Financing
Details
Endo International Competitors (44)
One of Endo International’s 44 competitors is Chiesi Farmaceutici, a Private Debt Financed company based in Parma, Italy.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Grifols | Corporation | Barcelona, Spain | ||||
| AbbVie | Corporation | North Chicago, IL |
Endo International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Endo International Patents
Endo International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10285396-B2 | Game tracking device | Active | 03-Jul-2014 | ||
| US-20160000061-A1 | Game tracking device | Active | 03-Jul-2014 | ||
| US-10294212-B2 | Inhibitors of the kynurenine pathway | Active | 14-Mar-2013 | ||
| US-20180030026-A1 | Inhibitors of the kynurenine pathway | Active | 14-Mar-2013 | ||
| CA-2905721-A1 | Urethral anastomosis device | Inactive | 14-Mar-2013 | A61B17/11 |
Endo International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Endo International Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Endo International Investments & Acquisitions (25)
Endo International’s most recent deal was a Corporate Asset Purchase with Nevakar Injectables (Six Development Stage -Injectable Product) for . The deal was made on 09-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Nevakar Injectables (Six Development Stage -Injectable Product) | 09-May-2022 | Corporate Asset Purchase | Buildings and Property | ||
| Biospecifics Technologies | 01-Dec-2020 | Merger/Acquisition | Pharmaceuticals | ||
| Somerset Pharma | 26-Apr-2018 | Merger/Acquisition | Pharmaceuticals | ||
| Aspen Holdings (branded and generic injectable and established products) | 01-Oct-2015 | Merger/Acquisition | Medical Supplies | ||
| Par Pharmaceutical Companies | 25-Sep-2015 | Merger/Acquisition | Pharmaceuticals |
Endo International Exits (6)
Endo International’s most recent exit was on 24-Jul-2014 from Grupo Farmaceutico Somar. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Grupo Farmaceutico Somar | 24-Jul-2014 | Completed |
|
||
| Paladin Pharma | 28-Feb-2014 | Completed |
|
||
| American Medical Systems | 11-Apr-2011 | Completed |
|
||
| HealthTronics | 15-Jul-2010 | Completed |
|
||
| Endo Pharmaceuticals Solutions | 05-Jan-2009 | Merger/Acquisition | Completed |
Endo International Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Auxilium Pharmaceuticals | Chesterbrook, PA | 1999 |
Endo International FAQs
-
When was Endo International founded?
Endo International was founded in 1920.
-
Where is Endo International headquartered?
Endo International is headquartered in PA.
-
What is the size of Endo International?
Endo International has 3,000 total employees.
-
What industry is Endo International in?
Endo International’s primary industry is Pharmaceuticals.
-
Is Endo International a private or public company?
Endo International is a Private company.
-
What is Endo International’s current revenue?
The current revenue for Endo International is .
-
How much funding has Endo International raised over time?
Endo International has raised $25.1B.
-
Who are Endo International’s investors?
Algos Pharmaceuticals, EIDP, Fidelity, and Kelso & Company have invested in Endo International.
-
Who are Endo International’s competitors?
Chiesi Farmaceutici, Novartis, Cipla, Grifols, and AbbVie are some of the 44 competitors of Endo International.
-
When was Endo International acquired?
Endo International was acquired on 14-Oct-2025.
-
Who acquired Endo International?
Endo International was acquired by Mallinckrodt Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
